Docetaxel With or Without AZD6244 in Melanoma
NCT01256359
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
83
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
Interventions
DRUG:
Docetaxel and AZD6244
DRUG:
Docetaxel and placebo
Sponsor
University of Oxford